M Hermanson
Overview
Explore the profile of M Hermanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pfeifer H, Cazzaniga G, van der Velden V, Cayuela J, Schafer B, Spinelli O, et al.
Leukemia
. 2020 Jan;
34(7):1970.
PMID: 31937894
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
2.
Pfeifer H, Cazzaniga G, van der Velden V, Cayuela J, Schafer B, Spinelli O, et al.
Leukemia
. 2019 Mar;
33(8):1910-1922.
PMID: 30858550
Minimal residual disease (MRD) is a powerful prognostic factor in acute lymphoblastic leukemia (ALL) and is used for patient stratification and treatment decisions, but its precise role in Philadelphia chromosome...
3.
Hermanson M, Hagglund G, Riad J, Rodby-Bousquet E
J Child Orthop
. 2017 Sep;
11(4):256-262.
PMID: 28904630
Purpose: Children with cerebral palsy (CP) are at increased risk for hip dislocation. This can be prevented in most cases using surveillance programmes that include radiographic examinations. Known risk factors...
4.
Hermanson M, Hagglund G, Riad J, Rodby-Bousquet E, Wagner P
Bone Joint J
. 2015 Oct;
97-B(10):1441-4.
PMID: 26430023
Hip displacement, defined in this study as a migration percentage (MP) of more than 40%, is a common, debilitating complication of cerebral palsy (CP). In this prospective study we analysed...
5.
Raper E, Davies S, Perkins B, Lamb H, Hermanson M, Soares A, et al.
Environ Geochem Health
. 2014 Dec;
37(3):545-56.
PMID: 25537165
Slag, a by-product from the iron and steel industry, has a range of applications within construction and is used in wastewater treatment. Historically considered a waste material, little consideration was...
6.
Eriksson A, Hermanson M, Wickstrom M, Lindhagen E, Ekholm C, Jenmalm Jensen A, et al.
Blood Cancer J
. 2012 Aug;
2:e81.
PMID: 22864397
Aberrantly expressed tyrosine kinases have emerged as promising targets for drug development in acute myeloid leukemia (AML). We report that AKN-028, a novel tyrosine kinase inhibitor (TKI), is a potent...
7.
Lion T, Watzinger F, Preuner S, Kreyenberg H, Tilanus M, de Weger R, et al.
Leukemia
. 2012 Mar;
26(8):1821-8.
PMID: 22395360
Hematopoietic stem cell transplantation is becoming an increasingly important approach to treatment of different malignant and non-malignant disorders. There is thus growing demand for diagnostic assays permitting the surveillance of...
8.
Fredriksson M, Barbany G, Liljedahl U, Hermanson M, Kataja M, Syvanen A
Leukemia
. 2003 Dec;
18(2):255-66.
PMID: 14671647
Single-nucleotide polymorphisms (SNPs) have the potential to be particularly useful as markers for monitoring of chimerism after stem cell transplantation (SCT) because they can be analyzed by accurate and robust...
9.
Lennartsson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L
Oncogene
. 1999 Oct;
18(40):5546-53.
PMID: 10523831
In this report we show that Tyr568 and Tyr570 are phosphorylated in vivo in the Kit/stem cell factor receptor (Kit/SCFR) following ligand-stimulation. By mutation of Tyr568 and Tyr570 to phenylalanine...
10.
Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, et al.
Cancer Res
. 1996 Jan;
56(1):164-71.
PMID: 8548759
The aim of this study was to examine platelet-derived growth factor alpha receptor (PDGFR-alpha) expression in gliomas of various degrees of malignancy and to correlate the findings with genetic alterations...